Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > It’s Sunday, week review & look ahead time again
View:
Post by canadafan on May 05, 2024 4:50pm

It’s Sunday, week review & look ahead time again

First, I'm very glad we got out of the international trade rules/ laws rabbit hole.
While the details c of international trade AKA our Chineees partner A.N...might be important, in reality very small important.
onc has huge relationships with a Roche, , on- going business with SOLTI ( Spain) , Incyte. 

canadian, USA & Caribesn incorperations. International business law, is extrealy complex.
No doubt various changes may or may not effect ONCs business dealings.
However, long before that becomes an inssue, they need FDA approval to market Pelareorep, fir cancer therapy.
No doubt in my mind what so ever, the likes of Roche, & Pfizer, have teams of lawyers dedicated to internatonal trade.
Moving forward. The FDA request from Onc for a phase 3 meeting, is probably on the top 5 list of business items Onc is dealing with.
It was mentioned thst we are on day 22 or so. The ducumet did indicate an answe within 75 days.
Could be in that light, anytime" within" 75 days.
Only the FDA can answer that. 

regardless of when, that answer will set the details & definition of the MBc long awaited phase 3 trial.
The pancreatic cancer next steps? That avenue is wide open. Other than they expect to finalize trial details first half of this year, meaning within next few weeks.
All we know for sure, there is a Q1 cc scheduled for this Thursday.
All of the past clinical updates have indicated positive outcomes.
Stay tuned.
crazy side note. It was mentioned in Andrew's D. Bio thst he brokered a $85million deal with ONC & A.N.
That is a huge upside potential few understand.
There are a lot if bridges to cross. However, even the start up phase 3, MBc does trigger milestone payments to oncolyitics biotech.
At the time , the deal included an upfront upfront payment. Plus mikstones , simplest being the first 20, 40;patients under trial.
longest & most significant being on- going royalties from a marketable product.
While they are miles away from that. The contract, does have value, should Pela get to phase 3.
again, great week ahead.
I was in hospital last week for 3 days , liver complications.due to Covid.
Today, lots of rest. Recovering & a bit better every day.
Always glad to be Canadian. amazing treatment. Zero costs.
We do pay a lot more taxes in Canada. However a hospital stay does not render me in financial concern.

Comment by itntdf on May 05, 2024 5:39pm
"No doubt in my mind what so ever, the likes of Roche, & Pfizer, have teams of lawyers dedicated to internatonal trade". that may be so, but AN has exclusive rights to pela for any approved treatment using pela in the exclusive territory which was defined in the agreement.  that territory includes prc, hong kong, macau, republic of singapore, south korea, and taiwan.  ...more  
Comment by canadafan on May 05, 2024 6:04pm
Any news updates, at anytime would certainly be welcome. few understand as you mentioned, should the A.N. Market for MBc get underway,there will be mikstones & royalties. both add value Onc as a company. royalties are the payment thst keeps on paying. There is a huge potential comercial upside to Onc. bring it on.
Comment by Snowdrift on May 06, 2024 7:39am
Glad to hear you're on the mend, CF.
Comment by Snowdrift on May 06, 2024 7:39am
Glad to hear you@re on the mend, CF.
Comment by Lesalpes29 on May 06, 2024 10:41am
Wall at 1.62. Manipulation for sure. GL
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities